论文标题
遗传疫苗有效性的纯观测方法的模拟和推断:没有关于种群行为的精确信息,没有可靠的疫苗有效性
Simulation and inference on purely observational methods of monitoring vaccine effectiveness post-deployment: none is reliable without precise information on population behaviour
论文作者
论文摘要
目前正在使用两种观察方法来监测部署后疫苗的有效性:明显的粗制方法,比较了接种疫苗的人群的速率测试阳性与未接种疫苗的人群的速率阳性;以及测试阴性案例控制(TNCC)方法。这两种方法给出了截然不同的结果。我们想知道这两种方法是否可靠。 我们假设均质人群或一个分区分为两个均质子集,它们仅在其非直接观察的寻求医疗保健行为上有所不同,包括接种疫苗的可能性。我们首先考虑统一的独立先验,这是在子集,疫苗接种状态和感染状态下住院的概率。我们从最终的模型中模拟,并观察TNCC估计值,原油估计值和贝叶斯中央95%置信区间对疫苗有效性表示为疫苗的有效性,称为对有或不进行疫苗接种的感染的数量比率。 对于这些宽阔的开放先验,即使人口均匀,贝叶斯95%的置信区间通常的宽度通常为近4个NAT(55倍),这意味着对于收集的数据而言,对于监测效率而言,收集到的任何数据都过于不确定性。确实存在一些紧密的先验,这些先验是有用的:有些导致TNCC更加准确,而另一些则更准确。 因此,仅使用自发选择进行测试的数据,我们发现这两种方法都不比其他方法更好,而且实际上,此数据中不存在所需的信息。我们得出的结论是,对疫苗有效性和副作用的有效监测需要有关人群行为的强大信息,或者需要进行的随机对照试验(RCT),而不仅仅是选择任何TNCC和粗制估计值,就可以提供我们更喜欢找到的结果。
Two observational methods are currently being used to monitor post-deployment vaccine effectiveness: the obvious crude method comparing rate testing positive per head of vaccinated population with that rate per head of unvaccinated population; and the test-negative case control (TNCC) method. The two methods give very different results. We want to know whether either method is reliable. We assume either a homogeneous population or one partitioned into two homogeneous subsets which differ only in their not-directly-observable healthcare-seeking behaviour including probability of getting vaccinated. We first consider uniform independent priors on the probabilities of being hospitalised conditional on subset, vaccination status, and infection status. We simulate from the resulting model and observe the TNCC estimate, the crude estimate, and the Bayesian central 95% confidence interval on vaccine effectiveness represented as log ratio of odds ratios for infection with and without vaccination. With these wide open priors, even when the population is homogeneous, the Bayesian 95% confidence interval typically has a width of nearly 4 nats (55-fold), implying too much uncertainty for the data collected to be of any use in monitoring effectiveness. There do exist some tight priors under which the data is useful: some lead to TNCC being more accurate while with others the crude estimate is more accurate. Thus using only data from those spontaneously choosing to be tested, we find that neither method is reliably better than the other, and indeed that the desired information is not present in this data. We conclude that effective monitoring of vaccine effectiveness and side-effects requires either strong information on the population's behaviour, or ongoing randomised controlled trials (RCTs), rather than just choosing whichever of TNCC and crude estimate gives the result we prefer to find.